Ocugen is a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and vaccines.
They announced yesterday that it will host a conference call to provide a business update and discuss its first quarter 2022 financial results tomorrow, May 6, before the market opens.
As soon as i saw the news, there were also...
Yesterday saw the price of Ocugen shoot up on the open as pre-market was showing huge open interest. This gain was quickly swallowed and lost due to a price gap formed pre market. The gap was filled in the last 15 minutes of the trading session so lets see what happens from here.
OCGN is a bio medical company that is extremely undervalued. We will see a huge buy order in this week. OCGN has a great potential to go to 190$ in near future.
